[go: up one dir, main page]

PT1474412E - Produção do delta9-tetra-hidrocanabinol - Google Patents

Produção do delta9-tetra-hidrocanabinol Download PDF

Info

Publication number
PT1474412E
PT1474412E PT03702721T PT03702721T PT1474412E PT 1474412 E PT1474412 E PT 1474412E PT 03702721 T PT03702721 T PT 03702721T PT 03702721 T PT03702721 T PT 03702721T PT 1474412 E PT1474412 E PT 1474412E
Authority
PT
Portugal
Prior art keywords
acid
thc
tetrahydrocannabinol
delta
production
Prior art date
Application number
PT03702721T
Other languages
English (en)
Inventor
Derek Mchattie
Neil John Goodwin
Nicolas James Archer
Christopher Murray
Alan Kenneth Greenwood
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0202396A external-priority patent/GB0202396D0/en
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of PT1474412E publication Critical patent/PT1474412E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Optical Integrated Circuits (AREA)
  • Pyrane Compounds (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Steroid Compounds (AREA)
PT03702721T 2002-02-01 2003-02-03 Produção do delta9-tetra-hidrocanabinol PT1474412E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0202396A GB0202396D0 (en) 2002-02-01 2002-02-01 Production of delta 9 tetrahydrocannabinol
GB0214022A GB0214022D0 (en) 2002-02-01 2002-06-18 Production of delta 9 tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
PT1474412E true PT1474412E (pt) 2008-07-04

Family

ID=27665366

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03702721T PT1474412E (pt) 2002-02-01 2003-02-03 Produção do delta9-tetra-hidrocanabinol

Country Status (17)

Country Link
US (3) US7524881B2 (pt)
EP (2) EP1803717B1 (pt)
JP (1) JP2005526715A (pt)
CN (2) CN100999513A (pt)
AT (1) ATE396984T1 (pt)
AU (2) AU2003205844B2 (pt)
BR (1) BR0307330A (pt)
CA (1) CA2474951A1 (pt)
DE (2) DE60321318D1 (pt)
DK (1) DK1474412T3 (pt)
ES (1) ES2305437T3 (pt)
NO (1) NO20043209L (pt)
NZ (2) NZ552547A (pt)
PT (1) PT1474412E (pt)
SI (1) SI1474412T1 (pt)
WO (1) WO2003064407A2 (pt)
ZA (1) ZA200405938B (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803717B1 (en) * 2002-02-01 2010-05-26 Resolution Chemicals Limited Production of delta 9 tetrahydrocannabinol
EP2311475B1 (en) * 2002-08-14 2016-08-31 GW Pharma Limited Extraction of pharmaceutically active cannabinoids from plant materials
GB2391865B (en) * 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
GB2408978B (en) * 2002-09-23 2006-04-05 Gw Pharma Ltd Methods of preparing delta-9 tetrahydrocannabinol from plant material
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
AU2005314021B2 (en) * 2004-12-09 2010-02-11 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
NZ601567A (en) 2005-09-29 2013-03-28 Albany Molecular Res Inc Process for production of delta-9-tetrahydrocannabinol
EP2046290A4 (en) * 2006-08-04 2011-08-17 Insys Therapeutics Inc AQUEOUS DRONABINOL FORMULATIONS
US20080103193A1 (en) * 2006-10-26 2008-05-01 Trevor Percival Castor Methods for making compositions and compositions for treating pain and cachexia
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
WO2009020666A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
US20090042974A1 (en) * 2007-08-07 2009-02-12 Anson David Parker Compositions And Methods Relating To Extensible Transgenic Vector Assembler, Pestilence Ridder, Plus Cannabinoid Producer
GB0807915D0 (en) * 2008-05-01 2008-06-04 Resolution Chemicals Ltd Production of delta 9 tetrahydrocannabinol
US8343553B2 (en) 2011-04-18 2013-01-01 Hospodor Andrew D Essential element extractor
DK2760444T3 (da) 2011-09-29 2020-07-27 Thc Pharm Gmbh The Health Concept Cannabinoidcarboxylsyrer, salte af cannabinoidcarboxylsyrer, fremstilling og anvendelse deraf
US9358259B2 (en) 2012-03-20 2016-06-07 Andrew David Hospodor Recycling cannabinoid extractor
US20150126754A1 (en) * 2012-05-03 2015-05-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising delta-9-tetrahydrocannabinol and a method for preparing such an isolate
US20130337052A1 (en) * 2012-06-19 2013-12-19 Patricia Linert System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication
US9155767B2 (en) 2012-10-18 2015-10-13 Andrew D. Hospodor Essential element management
EP4137142A1 (en) * 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof
US9199960B2 (en) * 2013-05-02 2015-12-01 Frederick R. Ferri Method and apparatus for processing herbaceous plant materials including the cannabis plant
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US20170312327A1 (en) * 2014-11-17 2017-11-02 Connoisseur Holdings, Llc Extraction devices, systems, and methods
US11034639B2 (en) 2015-01-22 2021-06-15 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
ES2801005T3 (es) * 2015-01-22 2021-01-07 Phytoplant Res S L Métodos de purificar canabinoides, composiciones y kits asociados
US10207198B2 (en) * 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US11040295B2 (en) 2015-02-06 2021-06-22 Joseph Francis Payack Method and apparatus for extracting plant oils using ethanol water
WO2016179247A1 (en) 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
US10913071B2 (en) 2016-03-09 2021-02-09 Pearson Incorporated Scalper apparatus and processing system
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
MX2018016411A (es) 2016-06-29 2019-05-09 Cannscience Innovations Inc Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.
US10322487B1 (en) 2016-07-15 2019-06-18 Pearson Incorporated Roller mill grinding apparatus with regenerative capability
CN109803643A (zh) * 2016-07-15 2019-05-24 S.S.斯坦纳公司 大麻生物质和大麻提取物中大麻二酚酸的脱羧
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
IT201700085508A1 (it) * 2017-07-26 2019-01-26 Inalco S R L Metodo per la produzione di cannabinoidi da varietà di canapa industriale
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US10406453B2 (en) * 2017-09-29 2019-09-10 NextLeaf Solutions Ltd. Cannabinoid extraction process using brine
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
CA3089490A1 (en) * 2018-01-29 2019-08-01 Phytoplant Research S.L Methods of purifying cannabinoids using liquid:liquid chromatography
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US11325133B1 (en) 2018-07-26 2022-05-10 Pearson Incorporated Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus
WO2020060959A1 (en) * 2018-09-17 2020-03-26 Sorbent Technologies, Inc. Methods for removing contaminants from plant-derived pharmaceuticals
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
WO2020150616A1 (en) * 2019-01-17 2020-07-23 Synthonics, Inc. Solid micellar compositions of cannabinoid acids
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
KR20220007855A (ko) * 2019-03-24 2022-01-19 오메가 라이프 사이언스 리미티드 전자 담배
GB2597178A (en) 2019-04-11 2022-01-19 Mantrose Haeuser Co Inc Cannabis delivery with protective glaze coating
CA3137735A1 (en) 2019-04-23 2020-10-29 Soma Oil Llc Cannabis processing systems and methods
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
WO2021055079A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
CN111039760A (zh) * 2019-12-16 2020-04-21 福建省中科生物股份有限公司 一种制备酚类化合物的方法
US11351476B2 (en) * 2020-01-07 2022-06-07 Agrify Corporation Method for chemical separation of cannabinoids
WO2021248235A1 (en) 2020-06-09 2021-12-16 Protonify Corporation Process for isolation and purification of thca from cannabis
AR123432A1 (es) 2020-09-04 2022-11-30 Herbolea Biotech S R L Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN115260005B (zh) * 2022-08-30 2024-01-30 晨光生物科技集团股份有限公司 一种纯化提取大麻二酚的方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342971A (en) * 1992-12-29 1994-08-30 The Australian National University Process for the preparation of dibenzo[b,d]pyrans
AU703958B2 (en) 1995-05-05 1999-04-01 Hauser Inc. High purity carnosic acid from rosemary and sage extracts by PH-controlled precipitation
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US20020039795A1 (en) 1998-10-26 2002-04-04 Elsohly Et Al Method of preparing delta-9-tetrahydrocannabinol
US6730519B2 (en) * 1998-10-26 2004-05-04 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
EP1803717B1 (en) * 2002-02-01 2010-05-26 Resolution Chemicals Limited Production of delta 9 tetrahydrocannabinol

Also Published As

Publication number Publication date
EP1474412A2 (en) 2004-11-10
WO2003064407A3 (en) 2003-10-16
AU2006252300A1 (en) 2007-01-25
US20050171361A1 (en) 2005-08-04
AU2006252300B2 (en) 2009-02-12
NO20043209L (no) 2004-10-28
NZ552547A (en) 2008-03-28
AU2003205844B2 (en) 2006-10-12
CA2474951A1 (en) 2003-08-07
NZ534430A (en) 2007-09-28
US7592468B2 (en) 2009-09-22
ZA200405938B (pt) 2006-05-31
EP1474412B1 (en) 2008-05-28
US7524881B2 (en) 2009-04-28
SI1474412T1 (sl) 2008-10-31
US20090253783A1 (en) 2009-10-08
WO2003064407A2 (en) 2003-08-07
EP1803717B1 (en) 2010-05-26
BR0307330A (pt) 2004-12-07
EP1803717A3 (en) 2007-07-11
DE60321318D1 (de) 2008-07-10
ATE396984T1 (de) 2008-06-15
EP1803717A2 (en) 2007-07-04
US20050049298A1 (en) 2005-03-03
CN1642934A (zh) 2005-07-20
DK1474412T3 (da) 2008-09-01
ES2305437T3 (es) 2008-11-01
DE60332776D1 (de) 2010-07-08
JP2005526715A (ja) 2005-09-08
CN100999513A (zh) 2007-07-18

Similar Documents

Publication Publication Date Title
PT1474412E (pt) Produção do delta9-tetra-hidrocanabinol
PT1133283E (pt) Um metodo de producao de particulas de farmaco
RS65604A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
MY142239A (en) Alkene separation process
HK1057897A1 (en) 4-Alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof.
ES2187483T3 (es) Procedimiento para la preparacion de acido a-lipoico esento de disolvente.
WO2002044194A1 (fr) Derives d'acide l-nucleique et procedes de synthese correspondants
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
PT1135517E (pt) Producao de acido ascorbico usando levedura
IT1319195B1 (it) Processo per la produzione dell'acido r(+)alfa-lipoico.
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
MXPA03001314A (es) Proceso para la preparacion de alfa'-clorocetonas.
EP1710251A4 (en) NEW PEPTIDE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE PEPTIDE
AU2321900A (en) Process for the preparation of alpha-aminoketones
AU3814800A (en) Enantiomers of mercapto lactones and processes for their synthesis
EP1258478A4 (en) PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS
AU2003287173A8 (en) Process for synthesizing l-y-methylene glutamic acid and analogs
EP1321141A4 (en) INHIBITORS OF PARATHORMONE PRODUCTION CONTAINING VITAMIN D3 DERIVATIVES
MXPA03012073A (es) Amidoderivados heterociclicos.
WO2000076966A3 (de) Indolinylamidderivate und deren verwendung als antivirale arzneimittel
WO2004026812A3 (de) Verfahren zur katalysator-freien herstellung von cyanophenolen aus methoxybenzonitrilen
PL376973A1 (pl) Sposób oczyszczania monoazotanu 1,4-butanodiolu
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them